INTRODUCTION
Khalvi Rasayana (drugs prepared using morter and pestel) is one amongst the novel drug design Protocols. It is an applied Pharmaceutical method of Phytometalo-mineral Pharma product preparations, without much disturbance to the Phytominerallo metallic ingredients used in the preparation, ecobiological acceptable nanotech particles are brought out in physiologically acceptable bondage patterns. Hence their safety, activity, cost effective utility are understood. Kapha Ketu Rasa is one such molecule in which Shanka Bhasma (incinerated conch shell), Shodita Tankana (purified borax), Shodita and Vastragalita Vatsanabha (purified fine powder of Aconitum ferox) and Pippali choorna (powder of Piper longum) are homogenously mixed and Bhavana (trituration) given with Ardraka Swarasa (juce of Zingeber officinalis) for 3 times. The Clinical practitioners are convinced today about, co-existence and complementary collaborative presentations of GERD and Bronchial asthma. Treating GERD along with the treatment of bronchial asthma will enhance the clinical success rate. Therefore modern medical practitioner will prescribe a co-drug acting on GERD along with the prescription for bronchial asthma to get good results.
At this juncture, it is worth to notice the pharmacology of Kapha Ketu Rasa in the same perspective. This product is essentially composed of drugs acting on GERD (Shankha Bhasma) and drugs effective in respiratory congestion and broncho constriction (Pippali, Tankana, Vatsanabha). As the clinical condition Tamaka Swasa (Bronchial asthma) is acute and life threatening at that moment.
[2] A fast acting, centrally effective drug is required hence very fast acting and more powerful drug Vatsanabha is logically present in Kapha Ketu Rasa.
The ultimate aim of any drug researches is appropriate management of the particular disease and promote and positive health based on the methodology prevalent in ancient times. 
MATERIALS AND METHODS

Selection of Patients
Objective parameter
Hb%, TLC, DLC, ESR, RBS, Urine; Sugar, Albumin, Microscopy, PEF.
Treatment: was assessed as very good improvement, good improvement, moderate improvement, mild improvement and no improvement.
1. Very good improvement -75% or above relief in signs and symptoms.
2. Good improvement -51 to 75% of signs and symptoms were relieved.
3. Moderate improvement -26 to 50% of signs and symptoms were relieved.
4. Mild improvement -1-25% of signs and symptoms were relieved.
No improvement -No improvement in signs and
symptoms were considered.
OBSERVATIONS AND RESULTS
Demographic data of 10 patients of pilot study Traid of symptoms were considered, baseline safety profiles along with peak expiratory flow was an objective parameter. Subjective symptoms and overall response were assessed based on specially designed scoring pattern and as a part of departmental contribution and in the view of Ayurvedic -Rasashastra drug research protocol, the Karmukata (action) of Kapha Ketu Rasa was also tried to assess based on the classical Guna (properties), Karma (action) and applied Bheshaja (medicinal) Karma theories. The clinical study was planned in such a way to evaluate the drug effect in majority including the aetio pathological and demographic understanding and echo social impact after the ethical clearance.
RESULTS OF PILOT STUDY
RESULTS
Discussion on observations
In the present study, demographically it was observed that maximum (28.57%) patients belonged to 41-50 year age group, immediately followed with 22.85% of 31-40 years age group, may be due to more stress and strain and as this age group people were of working classes and housewives, more exposed to dust, fumes, smoke, pollens etc. Most (68.57%) of them were males due to their dieting habits viz., consuming unwholesome, contaminated food etc. bad habits viz. smoking, alcohol etc. Maximum (85.71%) of patients were Hindus as the area where trial conducted was dominated by Hindu community. Majority (22.85% each) of patients were labours and housewives, may be due to more exposed to dust, fumes and smoke, patients having 1-5 years chronicity were reported in maximum (48.57%) may be due to the nature of the disease i.e. Yapya (manageable), reoccuring by the triggering factors like seasonal variations dust etc. Middle class people were more (57.14%) affected, may be due to their inability to afford for private consultation and purchase of costly medicine. Maximum (54.28%) patients had family history of Asthma which may be due to Bijadosha (genetic) producing Swasa or diet pattern etc. were also not withdrawn from their respective families and societies. Majority (62.85%) of patients were suffering in cold seasons it may be due to Kapha Prakopa (inceasing Kapha Dosha) Kala which had an impact on disease status and showed there was a strong influence of seasonal variation on disease status. Majority (57.14%) of patients had disturbed sleep, supporting to the symptoms of Tamaka Swasa, may be due to the severity of disease, made the patient restless. It was also observed that Kapha Pitta Prakruti patients were more (40%), followed by 31.42% belonged to Kapha Vata Prakruti. Mixed diet people were affected more (77.14%) may be due to predominance of life style modifications and also intake of Guru, Abhishyandi Ahara causing the disease. Majority (65.71%) of patients were exposed to dust, may be due to hygienic conditions of the concerned area and industries near the working place. [8] i.e. eradicates and reverses the pathophysiology of Swasa Roga, mainly mucolytic and expectorant and also inhibit the excessive secretions and discharges even though Ushna Veerya, 20% Sheeta Veerya (cold potency) of Kapha Ketu Rasa make it synergistically balanced and unwanted effects of drug and target cell specific activity is augmented which is unique holistic nature of Kapha Ketu Rasa.
Discussion on results
Kapha
Kapha Ketu Rasa is also analysed based on reverse pharmacology that it is Vatakapahahara (80%) and Kapahpittahara (20%), both these effects are as per the principles of Swasa chikitsa.
[9] The ingredients of Kapha Ketu Rasa have Deepana (digestive), Pachana, Swasaghna (anti asthmatic), Kasaghna (antitussive), Jwaraghna (febrifuge) and Rasayana (rejuvinative) properties. Katu -Kshara -Sheeta properties of Shanka Bhasma is effective in Pitta Kapha Shamana, Amlapitta (gastritis) and Swasahara effect.
[10] It is a direct reference for the role of Shanka Bhasma in curing GERD and hence Tamaka Swasa. Shankha Bhasma is a good drug in GERD and GERD coexists and triggers the bronchial asthma.
[ 
CONCLUSION
The pilot observational clinical study of Kapha Ketu Rasa on Tamaka Swasa was encouraging and showed relief in Kasa (95.2%), Ghurghurata (86.9%) and Swasakruchrata (86.2%) and drug intolerance, gastric irrition and other adverse effects were not observed. The clinical study proper showed statistically highly significant improvement in both subjective and objective parameters viz. Kasa (91%), Ghurghurata (83%) and Swasakruchrata (82%) including decrease in AEC, ESR, Differential eosinophil count and PEF was also statistically significantly improved. Kapha Ketu Rasa is an effective Vyadhi Pratyanika phyto steroidal mineral Shamana Rasayana in the management of Tamaka Swasa. None of the patients show any untoward effects during the study period.
